1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC104534.3 CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA KANK3 CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA NOTCH2NL CTRPv2 pan-cancer AAC -0.14 9e-06
mRNA TNPO2 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA PIK3C3 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA CAMK2B CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA MBTD1 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA CELSR3 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA VASH1 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA CTDP1 CTRPv2 pan-cancer AAC 0.16 1e-05
Download CSV